saPHenous - Peritoneal sHunt in reFractory ascites : aneglecteDtecHnique
Journal of Nepal Medical Association, 2006 Management of intractable ascites has always been a challenge. Peritoneovenous shunt (PVS) plays a major role in the surgery of intractable ascites in patients with liver cirrhosis.
P B Thapa +4 more
doaj +2 more sources
Peritoneovenous shunt in the management of the hepatorenal syndrome
Kidney International, 1986 The hepatorenal syndrome (HRS) is a terminal complication of severe liver disease associated with a mortality of 80 to 90%. Although the renal functional abnormalities in the HRS suggest prerenal azotemia, volume expansion with saline, albumin or ascitic fluid rarely results in reversal of the HRS because fluid redistributes from the vascular space ...
Linas, Stuart L. +4 more
openaire +3 more sources
Treatment of Chylous Ascites with Peritoneovenous Shunt (Denver Shunt) following Retroperitoneal Lymph Node Dissection in Patients with Urological Malignancies: Update of Efficacy and Predictors of Complications [PDF]
Journal of Urology, 2020 Adrian J González-Aguirre
exaly +2 more sources
Symptomatic Fluid Drainage: Peritoneovenous Shunt Placement. [PDF]
Semin Intervent Radiol, 2017 Ascites causes significant discomfort and has negative impact on patient's quality of life. Medical therapies including dietary restriction and diuretics are successful in only 40 to 44% of patients with malignant ascites and repeated paracentesis only ...
Yarmohammadi H, Getrajdman GI.
europepmc +2 more sources
Peritoneovenous (LeVeen) Shunt
JAMA, 1978 Because of the unusual clinical course of a patient with hepatic cirrhosis, refractory ascites, and hepatorenal syndrome, we were able to examine the complex interrelationships between massive ascites, renin-aldosterone activity, and renal and hepatic function before and after placement of a peritoneojugular vein (LeVeen) shunt.
Marlys H. Witte
openaire +2 more sources
Spontaneous central venous thrombosis and shunt occlusion following peritoneovenous shunt placement for intractable ascites. [PDF]
Ann R Coll Surg Engl, 2017 A 43-year-old man had a peritoneovenous shunt inserted for the treatment of chylous ascites secondary to myelofibrosis. Despite being on anticoagulation for superior mesenteric vein thrombosis, he developed shunt dysfunction within two weeks of insertion.
Hariharan D +4 more
europepmc +2 more sources
Peritoneovenous Shunt Scintigraphy to Assess Shunt Patency in Patients with Refractory Ascites [PDF]
Journal of Clinical and Experimental Hepatology, 2013 Mohamed Rela
exaly +2 more sources
Radionuclide Detection of Peritoneovenous Shunt Patency
Clinical Nuclear Medicine, 2003 The Denver peritoneovenous shunt, implanted for cirrhosis-related intractable ascites, appears to provide effective palliation in the majority of patients. A 53-year-old man had hepatitis B virus-related liver cirrhosis with multifocal hepatocellular carcinoma. Two months after injection with I-131 lipiodol he developed acute ascites decompensation and
Filip, Gemmel +6 more
openaire +3 more sources
Peritoneovenous Shunt for Hydrothorax Associated With Ascites
Archives of Surgery, 1982 Two patients with massive hydrothorax associated with ascites resistant to intensive long-term medical management were treated by insertion of a peritoneovenous (LeVeen) shunt. In each case the effusion was resolved within one month after insertion. With one revision each, the two shunts have remained clear for nine and 18 months.
C L, Hobbs, J L, Mullen, E F, Rosato
openaire +3 more sources
Angiographic Assessment of Peritoneovenous Shunt Malfunction
Archives of Surgery, 1981 On 12 patients with reaccumulation of ascitic fluid after peritoneovenous (LeVeen) shunt insertion, shuntograms were performed by direct percutaneous puncture of the venous limb of the shunt. Shunt function was evaluated by pressure determination and injection of sterile iodinated contrast material. The shuntogram correctly predicted the cause of shunt
M L, Schwartz, R P, Miller
openaire +3 more sources